stock

Becton Dickinson & Co. (BDX)

Share

Stay up to date

Becton, Dickinson and Company is a global medical technology company. The Company is engaged in the development, manufacture and sale of a range of medical supplies, devices, laboratory equipment and diagnostic products used by healthcare institutions, physicians, life science researchers, and others.

Financial Statements

Key Info

  • Industry: Surgical and Medical Instrument Manufacturing
  • Sector: Manufacturing
  • CEO Name: Thomas Polen

Key Statistics

  • Stock Price: $258.53
  • Dividend Yield: 1.4000000000000001%
  • Market Capitalization: $75,001,769,636
  • Shares Outstanding: 290,108,574
  • Number of Employees: 77,000
  • Trailing 12-Month EPS: $5.52
  • Trailing 12-Month DPS: $3.62
  • Payout Ratio: 65.60000000000001%

Important Dates

  • Next Earnings Date: 2023-11-09
  • Next Ex-Dividend Date: 2023-09-07

Price Trends

  • Current Stock Price: $258.53
  • 52-week high: $286.34
  • 52-week low: $212.77
  • 200-day moving average: $258.88
  • 50-day moving average: $270.36

Performance

  • 1-Month Price Return: -7.8%
  • 3-Month Price Return: -0.4%
  • 6-Month Price Return: 7.2%
  • 1-Year Price Return: 16.0%
  • 2-Year Price Return: 8.2%
  • 5-Year Price Return: 8.6%

Visit the Passiv Stock Directory

Data provided by IEX Cloud

For Canadian securities, listen to free conference calls on the TSX Quarterly Podcast